refractory angina

Gene therapy developer XyloCor adds $22.6M to expand clinical trial plans

With the extension to its Series A financing, XyloCor plans a clinical trial testing its gene therapy as an adjunct to coronary artery bypass graft surgery. A study in refractory angina is already underway.

By Frank Vinluan

BioPharma, Startups

XyloCor closes $17M Series A round to develop gene therapy for refractory angina

The Philadelphia-based company has an IND open with the FDA and plans to begin its clinical trial in the first half of next year.

By Alaric DeArment

The Top Appointment Scheduling Software for Wellness Clinics

Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform.

By PatientNow

These Are the Top-Rated Autism Therapy Centers in Texas

There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.

By Behavioral Innovations

Redefining Payer Operations: Data-Driven Strategies for the Future of Healthcare

This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.

By Veradigm